← Back to home

CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU)

Clinical trials for CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear

Sign up with your email to follow new studies for CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested to tame uncontrollable hives

Disease control Recruiting now

This study is testing whether an investigational oral drug called remibrutinib can better control the symptoms of chronic hives compared to a placebo. It will involve about 44 adults whose hives are not well-managed by standard antihistamine medications. Participants will take ei…

Matched conditions: CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU)

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU)

Get alerted when new CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear

New pill tested to tame uncontrollable hives